论文部分内容阅读
此文为美国传染病委员会的报告。其目的在于估价新头孢菌素类制剂的疗效,并为确定婴儿和儿童细菌性脑膜炎初期治疗的最佳方案提供依据。为了更全面的讨论关于脑膜炎的诊断和处理,读者可参考美国儿科学会指定课题组最近发表的一篇报告。本文则超出该报告,提出以新的头孢菌素类作为第一线治疗药物,并对某些脑膜炎患者推荐更短期的疗程。本文也将发表论述促使病人更快出院、减少医疗费用的代替治疗方案,以及脑膜炎病人在家庭治疗处理的问题。
This article is the report of the American Infectious Diseases Commission. Its purpose is to evaluate the efficacy of the new cephalosporin preparations and to provide a basis for identifying the best protocol for the initial treatment of bacterial meningitis in infants and children. For a more complete discussion on the diagnosis and management of meningitis, readers may refer to a recent report by the American Academy of Pediatrics Task Force. This article goes beyond the report by proposing new cephalosporins as a first-line treatment and recommending a shorter course of treatment for some meningitis patients. This article will also address the issue of alternative treatments that prompt patients to be discharged faster, reduce their medical costs, and treatment of patients with meningitis at home.